Equity Research
Company-level stock analysis, valuation, margins, balance sheet risk, and rating rationale.

Company-level stock analysis, valuation, margins, balance sheet risk, and rating rationale.
Post-publication reviews that check what happened after earlier Buy and Sell calls.
Daily filing-change notes comparing new 10-K language with prior-year disclosures.
Friday performance updates for the public LF0 research track record.
Universal Safety Products (UUU) 2026 10-K analysis comparing the 2 July 2026 filing with its prior-year 10-K, highlighting the Risk Factors section’s biggest…
Goldenwell Biotech (GWLL)’s Risk Factors section changed the most among 5 companies that filed 10-Ks on 1 July 2026, each compared against its prior-year filing.
Olenox Industries (OLOX)’s Business section changed the most among 3 companies that filed 10-Ks on 30 June 2026, each compared against its prior-year filing.
Beyond Air (XAIR)’s Business section changed the most among 15 companies that filed 10-Ks on 26 June 2026, each compared against its prior-year filing.
Anterix (ATEX)’s Business section changed the most among 6 companies that filed 10-Ks on 25 June 2026, each compared against its prior-year filing.
Daktronics (DAKT)’s MD&A section changed the most among 6 companies that filed 10-Ks on 24 June 2026, each compared against its prior-year filing.
Waitlist
More detailed equity research, scorecards, and performance analysis are coming. Add your email to be first in line.